Maynard Um
-
-
-
-
-
-
-
Rallybio Corporation (RLYB) Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
-
-
-
-
-
-
-
Rallybio Corporation (RLYB) Announces Initiation of Dosing in RLYB212 Phase 2 Clinical Trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Rallybio Corp. (RLYB)
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

